The SEC issued a final rule on October 26, 2022, Listing Standards for Recovery of Erroneously Awarded Compensation (commonly referred to as the “Clawback Rule”), to prevent executive officers from retaining excess compensation following an accounting restatement.
Planning for a registration statement includes assessing which financial statements are required to be included.
Third Harmonic Bio Closes Upsized Initial Public Offering of Shares of Common Stock Trading on the NASDAQ Global Market
CFGI’s Life Sciences team assisted Third Harmonic Bio (NASDAQ: THRD) with their initial public offering.
Each year at the AICPA & CIMA Conference, prominent members of the SEC, PCAOB, FASB, IASB and others meet to recap the year in regulation and discuss key initiatives and current developments.
CFGI’s Capital Markets team assisted Senti Biosciences, Incorporated (“Senti Bio”) with the completion of its merger with Dynamics Special Purpose Corporation (“DYNS”) (Nasdaq: DYNS), a special purpose acquisition company.
Background The SEC issued a long-anticipated proposed rule on March 21, 2022, surrounding the potential standardization of requirements for climate-related disclosures in registration statements and annual reports of public filers.